{{Rsnum
|rsid=3217869
|Gene=CCND2
|Chromosome=12
|position=4290804
|Orientation=plus
|GMAF=0.3907
|Gene_s=CCND2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 11.5 | 53.1 | 35.4
| HCB | 75.2 | 22.6 | 2.2
| JPT | 69.0 | 29.2 | 1.8
| YRI | 38.8 | 49.7 | 11.6
| ASW | 33.3 | 49.1 | 17.5
| CHB | 75.2 | 22.6 | 2.2
| CHD | 76.1 | 20.2 | 3.7
| GIH | 39.6 | 47.5 | 12.9
| LWK | 44.5 | 33.6 | 21.8
| MEX | 44.8 | 41.4 | 13.8
| MKK | 29.5 | 45.5 | 25.0
| TSI | 13.7 | 40.2 | 46.1
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23459443
  |Trait=QT interval (interaction)
  |Title=Drug-gene interactions and the search for missing heritability: a cross-sectional pharmacogenomics study of the QT interval.
  |RiskAllele=A
  |Pval=4E-6
  |OR=NR
  |ORtxt=NR
  }}

{{PMID Auto
|PMID=18174243
|Title=Association of single-nucleotide polymorphisms in the cell cycle genes with breast cancer in the British population.
|OA=1
}}

{{PMID Auto
|PMID=18281541
|Title=Effects of common germ-line genetic variation in cell cycle genes on ovarian cancer survival.
|OA=1
}}

{{PMID Auto
|PMID=19258477
|Title=Candidate gene analysis using imputed genotypes: cell cycle single-nucleotide polymorphisms and ovarian cancer risk.
|OA=1
}}

{{on chip | FTDNA}}
{{on chip | Illumina Human 1M}}